TOP TIERMARKET NEWSWIRE
News & sentiment

CRESCENT BIOPHARMA I (CBIO) — News & AI sentiment

CRESCENT BIOPHARMA I (CBIO) news roundup. 14 stories aggregated over the last 30 days. Average 30-day sentiment is 60.2/100. Recent insider activity (SEC Form 4, 90-day window): 0 purchases totalling $0 and 7 sales totalling $286K — net selling of $286K. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
0
30d stories
14
avg sentiment 60.2/100
Insider net (90d)
$286K
0 buys · 7 sells
Congress (90d)
0
0 buys · 0 sells

CBIO news in the last 24 hours, 7 days, 30 days and 90 days

How much CBIO coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowCBIO storiesAvg AI sentimentRead
Last 24 hours0—no coverage
Last 7 days0—no coverage
Last 30 days1460.2/100CBIO headlines →
Last 90 days2557.5/100CBIO headlines →

Latest stories on CBIO

H.C. Wainwright reiterates Crescent Biopharma stock rating at buy
Investing.com Analyst Ratings58 · neutralanalyst
Oct 19
Oct 15
Oct 15
Oct 15
Oct 15
Oct 6
Oct 6
Stifel reiterates Buy on Crescent Biopharma stock, $28 target
Investing.com Analyst Ratings61 · neutralanalyst
Oct 6
Crescent Biopharma stock rating upgraded to buy at H.C. Wainwright
Investing.com Analyst Ratings61 · neutralanalyst
Oct 6
Oct 6
Oct 5
Oct 5
Oct 5
Oct 5
Sep 25
Sep 25
Sep 25
Sep 25
Sep 15
Sep 9
Sep 9
Sep 3
Sep 3
Aug 24
Aug 3
Open CBIO in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →